Next report date
Report period
Q1 2024
EPS estimate
−4.19DKK
Revenue estimate
9.12 MDKK
−703.74 MDKK
342.79 MDKK
55.57 M
Om ZEALAND PHARMA A/S
Sektor
Bransch
VD
Adam Sinding Steensberg
Webbplats
Huvudkvarter
Soborg
Employees (FY)
253
Grundat
1997
ISIN
DK0060257814
FIGI
BBG00JVX9822
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
